Evidence map›Paper›PMID 40329212›Full record

Trial reportBMC psychiatry2025

Effect of inhibition of reactivated alcohol-associated memories with propranolol on alcohol craving.

Shuai Yu, Peng-Jiao Xu, Le Shi, Xiao-Yang Zhang, Chuan-Sheng Wang, Fang Wu, Xiao Li, Ping Cui, Rui-Ling Zhang, Lin Lu and 1 more

Erratum issuedAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Shuai Yu *Department of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China.
Peng-Jiao Xu *Department of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China.
Le ShiPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Chinese Academy of Medical Sciences Research Unit (No.2018RU006), Peking University, Beijing, 100191, China.
Xiao-Yang ZhangDepartment of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China.
Chuan-Sheng WangThe Second Affiliated Hospital of Xinxiang Medical University, Henan Province Key Laboratory of Biological Psychiatry (Henan Province Clinical Medical Research Center for Mental and Psychological Diseases), Xinxiang, Henan Province, China.
Fang WuDepartment of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China.
Xiao LiDepartment of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China.
Ping CuiDepartment of Addiction, Second Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan Province, China.
Rui-Ling ZhangThe Second Affiliated Hospital of Xinxiang Medical University, Henan Province Key Laboratory of Biological Psychiatry (Henan Province Clinical Medical Research Center for Mental and Psychological Diseases), Xinxiang, Henan Province, China.
Lin LuPeking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Chinese Academy of Medical Sciences Research Unit (No.2018RU006), Peking University, Beijing, 100191, China.
Ya-Hui XuDepartment of Sleep Medicine, the Second Affiliated Hospital of Xinxiang Medical University, Henan Collaborative Innovation Center for Prevention and Treatment of Mental Disorders, Xinxiang, Henan Province, China. 18737354427@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlcohol craving and relapse occur after the reactivation of alcohol reward memory. Previous studies suggest that drug-associated memory undergoes reconsolidation once retrieved by drug-associated stimuli. This study hypothesized that propranolol administration during memory reconsolidation induced by conditioned stimulus (CS) would significantly attenuate alcohol craving.

methodsA total of 40 patients with alcohol dependence who met the diagnostic criteria for alcohol dependence in DSMV were enrolled. The patients were randomized located into the memory retrievalpropranolol group (n = 20) and the memory retrievalplacebo group (n = 20) using the random number table. The memory retrievalpropranolol group used propranolol combined with a memory retrieval reconsolidation procedure, while the memory retrievalplacebo group used a placebo combined with a memory retrieval reconsolidation procedure. The Visual Analog Scale (VAS) was used to evaluate the degree of alcohol craving induced by images at stages of baseline measures, relevance learning, and memory test. The systolic blood pressure, diastolic blood pressure, and heartrate were applied to evaluate cue responsiveness. Repeated measures analysis of variance was used to compare the craving degree and independent samples t-tests were used for comparing demographic characteristics, scale scores between alcohol-dependent patient groups, and pre-post differences in heart rate, systolic blood pressure, and diastolic blood pressure at each experimental phase.

resultsRelevance learning stage: Compared with before learning, the levels of systolic blood pressure, diastolic blood pressure, and heart rate of the two groups increased in varying degrees after learning conditional stimulationrelevance learning CS+(all P < 0.05). Compared with pre-learning, both groups showed increased VAS scores during the Retrieval phase with statistically significant differences (F = 47.294、25.015, all P < 0.001). The memory test stage, after re-exposure to learned CS+, both groups showed varying degrees of increase in heart rate, systolic blood pressure, and diastolic blood pressure, with all differences reaching statistical significance (all P < 0.05). During the test phase, statistically significant between-group differences were found in heart rate difference, systolic blood pressure difference and diastolic blood pressure difference between the two groups (all P < 0.05). the retrieval-propranolol group demonstrated decreased VAS scores with statistical significance (F = 56.017, P < 0.001), while the retrieval-placebo group showed no statistically significant alterations in VAS scores (F = 0.183, P > 0.05).

conclusionsOur study demonstrated that propranolol administration after CS-induced retrieval could disrupt alcohol-associated memory reconsolidation and reduce alcohol craving. The finding provided a potential translational method to treat alcohol use disorder.

trial registrationThe protocol was registered at www.chictr.org.cn on October 13, 2023 (Chinese Clinical Trial Registry, identification number ChiCTR2300076633, Retrospectively registered).

Indexed as

Adrenergic beta-AntagonistsAlcoholismCravingMemory ConsolidationMental RecallPropranololAdultBlood PressureCuesFemaleHeart RateHumansMaleMiddle AgedAdrenergic beta-AntagonistsPropranololAlcohol use disorderCravingMemory retrievalPropranololReconsolidation

Identifiers

PMID40329212
PMCPMC12057275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.